Adipsin Activators

Adipsin, also recognized as complement factor D (CFD), is a serine protease primarily synthesized and secreted by adipocytes, though its expression is not limited to adipose tissue. It plays a pivotal role within the complement system, specifically in the alternative pathway, by facilitating the activation of complement component C3. Adipsin cleaves factor B, a constituent of the C3 convertase complex, into its active forms, factor Ba and Bb, thereby instigating the formation of the alternative pathway C3 convertase (C3bBb). This activation event is instrumental in amplifying the complement cascade, leading to processes such as opsonization, inflammation, and immune cell recruitment.

The activation mechanisms of adipsin are intricately regulated. Transcriptionally, its expression is subject to modulation by various factors including hormones, cytokines, and nutritional status. For example, insulin and glucocorticoids can upregulate adipsin expression, while inflammatory cytokines such as TNF-α and interleukins may exert downregulatory effects. Moreover, post-translational modifications such as glycosylation and proteolytic processing contribute to modulating its activity and secretion. Notably, adipsin activation is tightly regulated to preserve homeostasis, with dysregulation implicated in a spectrum of pathological conditions including obesity, diabetes, and autoimmune diseases. Furthermore, its activation can be influenced by upstream signaling pathways such as the PI3K-Akt and MAPK pathways, which converge on transcription factors like PPARγ and NF-κB, thus impacting adipsin expression levels. A comprehensive understanding of the intricate mechanisms governing adipsin activation is imperative for elucidating its physiological functions and implications across various disease contexts.